This is a preview of subscription content, log in via an institution to check access.
Reference
Kostic M, et al. Cost-utility of tafenoquine vs. primaquine for the radical cure (prevention of relapse) of Plasmodium vivax malaria. Journal of Chemotherapy : 16 Sep 2019. Available from: URL: https://doi.org/10.1080/1120009X.2019.1665874
Rights and permissions
About this article
Cite this article
Tafenoquine cost-effective option in Plasmodium vivax malaria. PharmacoEcon Outcomes News 838, 29 (2019). https://doi.org/10.1007/s40274-019-6274-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6274-y